Statement of Organization, Functions, and Delegations of Authority, 57189-57190 [2015-24006]
Download as PDF
Federal Register / Vol. 80, No. 183 / Tuesday, September 22, 2015 / Notices
hour, which includes time to review the
interview protocol with the interviewer,
respond to the interview questions, and
review a summary report about the
Champion’s practices. The summary
will be written as a success story and
will be posted on the CDC Web site.
Additional Information
Information received from nominees
will be stored in a password protected
file on a secure server. The challenge
Web site may post the number of
nominations received but will not
include information about individual
nominees. The database of information
submitted by nominees will not be
posted on the Web site. Personal
information collected and stored from
nominees will only include general
details, such as the organization name,
address, and contact information of the
nominee. This type of information is
generally publically available. The
nomination form and submission will
collect and store only aggregate clinical
data through the nomination process; no
individual identifiable patient data will
be collected or stored. Confidential or
propriety data, clearly marked as such,
will be secured to the full extent
allowable by law.
Information for selected Champions,
such as the hospital or health system’s
name, location, VTE prevention
outcomes, and practices that support
HA–VTE prevention will be shared
through press releases, the challenge
Web site, social media, and other HHS/
CDC resources. Summary data on the
types of systems and processes used to
increase VTE prevention will be shared
in documents or other communication
products that describe generally used
practices for successful VTE prevention.
HHS/CDC will use the summary data
only as described.
tkelley on DSK3SPTVN1PROD with NOTICES
Compliance With Rules and Contacting
Contest Winners
Finalists must comply with all terms
and conditions of these official rules,
and winning is contingent upon
fulfilling all requirements herein. The
finalists will be notified by email,
telephone, or mail after the date of
judging.
Privacy
Personal information provided by
entrants on the nomination form
through the challenge Web site will be
used to contact selected finalists.
Information is not collected for
commercial marketing. Winners are
permitted to cite that they won this
challenge.
The names, cities, and states of
selected Champions will be made
VerDate Sep<11>2014
17:39 Sep 21, 2015
Jkt 235001
available in HHS/CDC’s educational
materials on VTE prevention and at
recognition events.
General Conditions
HHS/CDC reserves the right to cancel
suspend, and/or modify the challenge,
or any part of it, for any reason, as HHS/
CDC’s sole discretion.
Dated: September 15, 2015.
Sandra Cashman,
Acting Director, Division of the Executive
Secretariat, Office of the Chief of Staff,
Centers for Disease Control and Prevention.
[FR Doc. 2015–23990 Filed 9–21–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 80 FR 34643–34644,
dated June 6, 2015) is amended to
reflect the reorganization of the National
Institute for Occupational Safety and
Health, Centers for Disease Control and
Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title and
function statements for the Division of
Respiratory Disease Studies (CCH) and
insert the following:
Respiratory Health Division (CCH).
The Respiratory Health Division (RHD)
seeks to advance protection against
work-related hazards and exposures that
cause or contribute to respiratory
illness, injury, and death and to
promote workplace-based interventions
that improve respiratory health. To
accomplish its mission, the Division
gathers and synthesizes information,
makes recommendations, and delivers
products and services to a range of
stakeholders, including partners able to
effect prevention. Specifically, RHD: (1)
Prevents work-related respiratory
disease and improves workers’
respiratory health by generating new
knowledge and transferring that
knowledge into practice; (2) plans,
designs, and conducts a national
research program relevant to preventing
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
57189
occupational respiratory disease and
optimizing workers’ respiratory health;
(3) upon request, conducts hazard
evaluations and provides technical
assistance to address challenges,
including emerging issues, in
occupational respiratory disease; (4)
plans, designs, and conducts a national
surveillance program for occupational
and work-related respiratory disease; (5)
communicates study findings to prevent
occupational respiratory disease and
optimize workers’ respiratory health,
and evaluates the effectiveness of these
communications; (6) administers a
program of legislatively mandated
medical monitoring services for coal
miners under the Federal Mine Safety
and Health Act of 1977; and (7) provides
rewarding educational and training
opportunities in occupational and workrelated respiratory disease prevention to
visiting scientists, Epidemiologic
Investigations Service Officers, fellows,
residents, interns, students and others
through a variety of temporary
assignments in various Division
activities.
Office of the Director (CCH1). Directs
and manages the operations of the
Respiratory Health Division.
Field Studies Branch (CCHB). (1)
Plans, designs, and conducts short- and
long-term field investigations relevant to
preventing occupational respiratory
diseases and optimizing workers’
respiratory health; (2) responds to
requests for health hazard evaluations
and technical assistance relevant to
occupational respiratory disease; (3)
conducts morbidity and mortality
studies relating to occupational
respiratory diseases in selected worker
populations and the general population
in order to identify causal agents and
other risk factors, quantify exposure
effect relationships, and evaluate
prevalence and severity of specific
respiratory diseases; (4) conducts
environmental studies, medical test
evaluations, industrial hygiene research,
laboratory research, demonstrations of
workplace exposures and controls, and
studies the challenges created by new
technologies; (5) provides statistical
design and implements data analysis
and verification for Division research
projects; and (6) develops and evaluates
research methods of data collection,
processing, and statistical analysis that
are relevant to the Division mission,
including medical tests, sampling
approaches and equipment, sample
analyses, exposure and dose assessment
and modeling (including dermal
exposure), bioavailability of exposures,
biomarkers of exposure and health
effects, and protective measures.
E:\FR\FM\22SEN1.SGM
22SEN1
tkelley on DSK3SPTVN1PROD with NOTICES
57190
Federal Register / Vol. 80, No. 183 / Tuesday, September 22, 2015 / Notices
Surveillance Branch (CCHD). (1)
Collects, analyzes, and disseminates
accurate and timely health and hazard
information related to occupational
respiratory diseases and workers’
respiratory health, and collaborates in
the establishment and analysis of health
surveillance systems at the national and
state level in order to: (a) provide
information relating to overall
incidence, prevalence, mortality, and
impact of occupational respiratory
diseases and workers’ respiratory
health; (b) describe the occurrence of
specific diseases with regard to
occupation, industry, exposures,
geography, demographic characteristics,
temporal trends, and other relevant
factors for which information is
available; (c) describe the distribution
and trends in occupational exposure to
agents responsible for respiratory
diseases; (d) identify emerging risks for
respiratory disease; (e) assess racial/
ethnic and other disparities in the
occurrence of occupational respiratory
diseases and occupational exposures to
agents responsible for respiratory
diseases; and (f) evaluate impact of
interventions, policies, and program
activities on the occurrence of
occupational respiratory disease; (2)
synthesizes data to frame
recommendations for priority setting,
hypothesis generation, and improved
methods for data collection; (3)
disseminates information through
development and publication of timely
information and reports describing
workplace hazards and exposures and
work-related occupational lung
diseases, and application of
communication science, media
principles, and web design to enhance
access to and use of data and
information; (4) develops and evaluates
innovative surveillance methods; (5)
coordinates with other Federal agencies,
promulgates rules, and implements
programs as authorized by the Federal
Mine Safety and Health Act of 1977 and
its subsequent amendments, to provide
for the collection and reporting of health
and hazard surveillance data related to
occupational respiratory diseases in coal
miners, including planning,
coordinating, and processing the
medical examinations provided for
miners, operating an approval program
for participating medical facilities and
physicians, and evaluating and
approving employer programs for the
examination of miners in accordance
with published regulations; (6) provides
technical assistance and
recommendations concerning medical
VerDate Sep<11>2014
17:39 Sep 21, 2015
Jkt 235001
screening and health surveillance of
workers exposed to respiratory hazards
in the workplace, including
administering a national program of
spirometry training, providing training
and testing on the classification of
radiographs for the pneumoconioses,
and collaborating with national (e.g.,
American College of Radiology,
American Thoracic Society) and
international (e.g., International Labour
Organization) groups to develop and
improve occupational respiratory
disease medical surveillance methods;
and (7) establishes collaborations to
identify, support, and evaluate
interventions designed to improve
respiratory health in the workplace.
James Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2015–24006 Filed 9–21–15; 8:45 am]
BILLING CODE 4160–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–15–15AOX]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Harmful Algal Bloom Illness
Surveillance System (HABISS)—NEW—
National Center for Emerging and
Zoonotic Infectious Diseases, Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID)
is requesting approval for surveillance
activities through Harmful Algal Bloomrelated Illness Surveillance System
(HABISS). HABISS data surveillance
was previously covered under OMB
Control No. 0920–0004. Previous
Harmful Algal Bloom (HAB)
surveillance under HABISS ceased due
to defunding. NCEZID is now managing
the HAB surveillance module.
Surveillance through HABISS is now a
priority within NCEZID due to the Great
Lakes Restorative Initiative.
The goal of the Harmful Algal Bloomrelated Illness Surveillance System
(HABISS) is to receive data on harmful
algal blooms (HABs) and human and
animal illnesses related to HAB
exposures. Data reported to HABISS
will be accessible to state health
departments, federal partners and other
stakeholders to better characterize HABs
and single human and animal illness
related to HAB exposures and to inform
future prevention efforts.
Data will be collected electronically,
with data elements collected via the
National Outbreak Reporting System
(NORS). Single human and animal
illnesses related to HAB exposures, and
environmental data about HABs will be
voluntarily reported by state agencies.
The data collected will be analyzed and
presented through summaries and
reports.
The total burden is 57 hours.
E:\FR\FM\22SEN1.SGM
22SEN1
Agencies
[Federal Register Volume 80, Number 183 (Tuesday, September 22, 2015)]
[Notices]
[Pages 57189-57190]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-24006]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Statement of Organization, Functions, and Delegations of
Authority
Part C (Centers for Disease Control and Prevention) of the
Statement of Organization, Functions, and Delegations of Authority of
the Department of Health and Human Services (45 FR 67772-76, dated
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as
amended most recently at 80 FR 34643-34644, dated June 6, 2015) is
amended to reflect the reorganization of the National Institute for
Occupational Safety and Health, Centers for Disease Control and
Prevention.
Section C-B, Organization and Functions, is hereby amended as
follows:
Delete in its entirety the title and function statements for the
Division of Respiratory Disease Studies (CCH) and insert the following:
Respiratory Health Division (CCH). The Respiratory Health Division
(RHD) seeks to advance protection against work-related hazards and
exposures that cause or contribute to respiratory illness, injury, and
death and to promote workplace-based interventions that improve
respiratory health. To accomplish its mission, the Division gathers and
synthesizes information, makes recommendations, and delivers products
and services to a range of stakeholders, including partners able to
effect prevention. Specifically, RHD: (1) Prevents work-related
respiratory disease and improves workers' respiratory health by
generating new knowledge and transferring that knowledge into practice;
(2) plans, designs, and conducts a national research program relevant
to preventing occupational respiratory disease and optimizing workers'
respiratory health; (3) upon request, conducts hazard evaluations and
provides technical assistance to address challenges, including emerging
issues, in occupational respiratory disease; (4) plans, designs, and
conducts a national surveillance program for occupational and work-
related respiratory disease; (5) communicates study findings to prevent
occupational respiratory disease and optimize workers' respiratory
health, and evaluates the effectiveness of these communications; (6)
administers a program of legislatively mandated medical monitoring
services for coal miners under the Federal Mine Safety and Health Act
of 1977; and (7) provides rewarding educational and training
opportunities in occupational and work-related respiratory disease
prevention to visiting scientists, Epidemiologic Investigations Service
Officers, fellows, residents, interns, students and others through a
variety of temporary assignments in various Division activities.
Office of the Director (CCH1). Directs and manages the operations
of the Respiratory Health Division.
Field Studies Branch (CCHB). (1) Plans, designs, and conducts
short- and long-term field investigations relevant to preventing
occupational respiratory diseases and optimizing workers' respiratory
health; (2) responds to requests for health hazard evaluations and
technical assistance relevant to occupational respiratory disease; (3)
conducts morbidity and mortality studies relating to occupational
respiratory diseases in selected worker populations and the general
population in order to identify causal agents and other risk factors,
quantify exposure effect relationships, and evaluate prevalence and
severity of specific respiratory diseases; (4) conducts environmental
studies, medical test evaluations, industrial hygiene research,
laboratory research, demonstrations of workplace exposures and
controls, and studies the challenges created by new technologies; (5)
provides statistical design and implements data analysis and
verification for Division research projects; and (6) develops and
evaluates research methods of data collection, processing, and
statistical analysis that are relevant to the Division mission,
including medical tests, sampling approaches and equipment, sample
analyses, exposure and dose assessment and modeling (including dermal
exposure), bioavailability of exposures, biomarkers of exposure and
health effects, and protective measures.
[[Page 57190]]
Surveillance Branch (CCHD). (1) Collects, analyzes, and
disseminates accurate and timely health and hazard information related
to occupational respiratory diseases and workers' respiratory health,
and collaborates in the establishment and analysis of health
surveillance systems at the national and state level in order to: (a)
provide information relating to overall incidence, prevalence,
mortality, and impact of occupational respiratory diseases and workers'
respiratory health; (b) describe the occurrence of specific diseases
with regard to occupation, industry, exposures, geography, demographic
characteristics, temporal trends, and other relevant factors for which
information is available; (c) describe the distribution and trends in
occupational exposure to agents responsible for respiratory diseases;
(d) identify emerging risks for respiratory disease; (e) assess racial/
ethnic and other disparities in the occurrence of occupational
respiratory diseases and occupational exposures to agents responsible
for respiratory diseases; and (f) evaluate impact of interventions,
policies, and program activities on the occurrence of occupational
respiratory disease; (2) synthesizes data to frame recommendations for
priority setting, hypothesis generation, and improved methods for data
collection; (3) disseminates information through development and
publication of timely information and reports describing workplace
hazards and exposures and work-related occupational lung diseases, and
application of communication science, media principles, and web design
to enhance access to and use of data and information; (4) develops and
evaluates innovative surveillance methods; (5) coordinates with other
Federal agencies, promulgates rules, and implements programs as
authorized by the Federal Mine Safety and Health Act of 1977 and its
subsequent amendments, to provide for the collection and reporting of
health and hazard surveillance data related to occupational respiratory
diseases in coal miners, including planning, coordinating, and
processing the medical examinations provided for miners, operating an
approval program for participating medical facilities and physicians,
and evaluating and approving employer programs for the examination of
miners in accordance with published regulations; (6) provides technical
assistance and recommendations concerning medical screening and health
surveillance of workers exposed to respiratory hazards in the
workplace, including administering a national program of spirometry
training, providing training and testing on the classification of
radiographs for the pneumoconioses, and collaborating with national
(e.g., American College of Radiology, American Thoracic Society) and
international (e.g., International Labour Organization) groups to
develop and improve occupational respiratory disease medical
surveillance methods; and (7) establishes collaborations to identify,
support, and evaluate interventions designed to improve respiratory
health in the workplace.
James Seligman,
Acting Chief Operating Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2015-24006 Filed 9-21-15; 8:45 am]
BILLING CODE 4160-18-P